|
1.
|
2024/09
|
|
Clinical evaluation of two interferon-gamma release assays for diagnostic tests of tuberculosis infection in a tertiary hospital
|
|
2.
|
2024/08/30
|
|
Evaluating the timing of triple therapy initiation for the treatment of asthma in Japan: prompt versus delayed.
|
|
3.
|
2024/08/28
|
|
A case of pulmonary mycobacterium heckeshornense infection in which the causative microorganism was difficult to identify.
|
|
4.
|
2024/07
|
|
Real-world characteristics of patients with asthma initiating fluticasone furoate/umeclidinium/vilanterol single-inhaler triple therapy in Japan.
|
|
5.
|
2024/06/28
|
|
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer
|
|
6.
|
2024/04/16
|
|
Obstructive sleep apnea: The most prevalent, yet most unnoticed respiratory disorder.
|
|
7.
|
2024/02/09
|
|
Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan.
|
|
8.
|
2024
|
|
Cytomegalovirus pneumonitis preceded infectious mononucleosis
in an immunocompetent middle-aged female
|
|
9.
|
2023/07/07
|
|
Pneumatosis cystoides intestinalis developing during chemotherapy for pulmonary nontuberculous mycobacterial disease.
|
|
10.
|
2023/05
|
|
Improving the diagnosis of chronic obstructive pulmonary disease starts with appropriate medical education.
|
|
11.
|
2023/05
|
|
One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan.
|
|
12.
|
2023/04/01
|
|
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis
|
|
13.
|
2023/03/07
|
|
Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies.
|
|
14.
|
2023/03
|
|
Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies.
|
|
15.
|
2023/01/11
|
|
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
|
|
16.
|
2023
|
|
Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan.
|
|
17.
|
2022/10
|
|
Filaggrin-deficient rats generated using zinc-finger nucleases spontaneously exhibit dry scaly skin.
|
|
18.
|
2022/08/26
|
|
IgG4-related lung disease with multifocal pulmonary consolidations near the pleura: A case report
|
|
19.
|
2022/08
|
|
HDL and sleep: beyond cardiovascular diseases and allergy.
|
|
20.
|
2022/06/11
|
|
CD44 is critical for the enhancing effect of hyaluronan in allergen-specific sublingual immunotherapy in a murine model of chronic asthma
|
|
21.
|
2022/04/15
|
|
Pneumococcal Pneumonia Co-infection with Mycobacterium avium and Nocardia cyriacigeorgica in an Immunocompetent Patient.
|
|
22.
|
2022/01
|
|
Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020.
|
|
23.
|
2021/12/26
|
|
Role of interleukin 5-induced eosinophilia in interleukin 33-triggered airway inflammation in mice
|
|
24.
|
2021/11
|
|
Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12.
|
|
25.
|
2021/11
|
|
Tumor PD-L1 and VEGF Expression, and CD8 T Cell Infiltration Predict Clinical Response to Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
|
|
26.
|
2021/08
|
|
A novel automated immunoassay for serum NY-ESO-1 and XAGE1
antibodies in combinatory prediction of response to anti-programmed cell
death-1 therapy in non-small-cell lung cancer
|
|
27.
|
2021/06
|
|
Prospective associations of sleep apnea, periodic limb movements, and plasma fibrinogen level.
|
|
28.
|
2021/04/21
|
|
Patient-reported dyspnea and health predict waitlist mortality in patients waiting for lung transplantation in Japan.
|
|
29.
|
2021/03
|
|
Sleep quality and its association with health-related quality of life of patients on lung transplantation waitlist in Japan.
|
|
30.
|
2021/02/01
|
|
Impact of sleep-disordered breathing on glucose metabolism among individuals with a family history of diabetes: the Nagahama study.
|
|
31.
|
2021/01
|
|
Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report
|
|
32.
|
2020/11
|
|
Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data.
|
|
33.
|
2020/10
|
|
Successful treatment of gastric cancer after complete response of lung cancer by nivolumab: a case report
|
|
34.
|
2020/09
|
|
Sex differences between women and men with COPD: A new analysis of the 3CIA study
|
|
35.
|
2020/07
|
|
An unusual but unmissable link between summer-type hypersensitivity pneumonitis and asthma in an old house.
|
|
36.
|
2020/07
|
|
Role of serum periostin in severe obstructive sleep apnea with albuminuria: an observational study.
|
|
37.
|
2020/05/05
|
|
Analysis of Optimal Health-Related Quality of Life Measures in Patients Waitlisted for Lung Transplantation.
|
|
38.
|
2020/03
|
|
Analysis of optimal health-related quality of life measures in patients waitlisted for lung transplantation.
|
|
39.
|
2020/02
|
|
Detachment and recovery of an X-ray opaque tip of a disposable guide sheeth kit: A rare complication of endobronchial ultrasound-guided transbronchial biopsy.
|
|
40.
|
2020/01/15
|
|
Thoracoscopic Findings in IgG4-related Pleuritis.
|
|
41.
|
2020
|
|
Clinical Analysis of Pulmonary Mycobacterium kansasii Disease.
|
|
42.
|
2020
|
|
Mechanical insufflation-exsufflation-related bilateral pneumothorax
|
|
43.
|
2019/12
|
|
Comparison between electronic and paper versions of patient-reported outcome measures in subjects with chronic obstructive pulmonary disease: an observational study with a cross-over administration.
|
|
44.
|
2019/11/14
|
|
Pulmonary Mycobacterium avium complex disease requiring differentiation from recurrence of lung cancer during the follow-up period for lung cancer
|
|
45.
|
2019/11
|
|
A randomized controlled trial of telemedicine for long-term sleep apnea CPAP management.
|
|
46.
|
2019/09
|
|
Adrenal gland size in obstructive sleep apnea: Morphological assessment of hypothalamic pituitary adrenal axis activity.
|
|
47.
|
2019/07
|
|
How different are COPD-specific patient reported outcomes, health status, dyspnoea and respiratory symptoms? An observational study in a working population.
|
|
48.
|
2019/05
|
|
Low levels of PaO2 after long-term noninvasive ventilation are a poor prognostic factor in patients with restrictive thoracic disease.
|
|
49.
|
2019/03
|
|
Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?
|
|
50.
|
2019/02
|
|
External validation and recalculation of the CODEX index in COPD patients. A 3CIAplus Cohort Study.
|
|
51.
|
2018/10
|
|
Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease.
|
|
52.
|
2018/08
|
|
Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study.
|
|
53.
|
2018/07
|
|
Impact of sleep characteristics and obesity on diabetes and hypertension across genders and menopausal status: the Nagahama study.
|
|
54.
|
2018/06
|
|
Gender differences in morphological and functional outcomes after mandibular setback surgery.
|
|
55.
|
2018/06
|
|
The relationship between cephalogram analysis and oxygen desaturation Index during sleep in patients submitted for mandibular setback surgery.
|
|
56.
|
2018/05
|
|
Health-related quality of life measurement in patients with chronic respiratory failure
|
|
57.
|
2018/04
|
|
Associations of obstructive sleep apnea with truncal skeletal muscle mass and density.
|
|
58.
|
2018/03
|
|
3CIA collaboration: Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
|
|
59.
|
2018/01
|
|
Impact of long-term continuous positive airway pressure on liver fat in male obstructive sleep apnea patients with fatty liver.
|
|
60.
|
2017
|
|
Analysis of the relationship between health status and mortality in hypercapnic patients with noninvasive ventilation.
|
|
61.
|
2017
|
|
Asymmetry in acute exacerbation of idiopathic pulmonary fibrosis.
|
|
62.
|
2017
|
|
Changes in habitual sleep duration after continuous positive airway pressure for obstructive sleep apnea.
|
|
63.
|
2017
|
|
Comparison of different disease-specific health-related quality of life measurements in patients with long-term noninvasive ventilation.
|
|
64.
|
2017
|
|
Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?
|
|
65.
|
2017
|
|
Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis.
|
|
66.
|
2017
|
|
Initiatives BPCO, EABPCO, Leuven and 3CIA study groups. A simple algorithm for the identification of clinical COPD phenotypes.
|
|
67.
|
2017
|
|
Relationship between obstructive sleep apnea and endogenous carbon monoxide.
|
|
68.
|
2017
|
|
The association between health-related quality of life and disease progression in indiopathic pulmonary fibrosis: a prospective cohort study.
|
|
69.
|
2017
|
|
The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
|
|
70.
|
2017
|
|
Validation of the Japanese Severe Respiratory Insufficiency Questionnaire in hypercapnic patients with noninvasive ventilation.
|
|
71.
|
2016
|
|
Aquaporin-3 potentiates allergic airway inflammation in ovalbumin-induced murine asthma.
|
|
72.
|
2016
|
|
Changes in energy metabolism after continuous ositive airway pressure for obstructive sleep apnea.
|
|
73.
|
2016
|
|
Evaluation of bone mineral density by computed tomography in patients with obstructive sleep apnea.
|
|
74.
|
2016
|
|
Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome.
|
|
75.
|
2016
|
|
Plasma incretin levels and depeptidyl peptidase-4 activity in patients with obstructive sleep apnea.
|
|
76.
|
2016
|
|
Platelet aggregability in patients with interstitial pneumonias.
|
|
77.
|
2016
|
|
Role of mitochondrial hydrogen peroxide induced by intermittent hypoxia in airway epithelial wound repair in vitro.
|
|
78.
|
2015
|
|
Among metabolic factors, significance of fasting and postprandial increases in acyl and desacyl ghrelin and the acyl/desacyl ratio in obstructive sleep apnea before and after treatment.
|
|
79.
|
2015
|
|
Association between endothelial function (assessed on reactive hyperemia peripheral arterial tonometry) and obstructive sleep apnea, visceral fat accumulation, and serum adiponectin.
|
|
80.
|
2015
|
|
Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias.
|
|
81.
|
2015
|
|
Impact of obstructive sleep apnea on liver fat accumulation according to sex and visceral obesity.
|
|
82.
|
2015
|
|
Lung allocation score and health-related quality of life in Japanese candidates for lung transplantation.
|
|
83.
|
2015
|
|
Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
|
|
84.
|
2015
|
|
Obstructive sleep apnea and abdominal aortic calcification: Is there an association independent of comorbid risk factors?
|
|
85.
|
2015
|
|
The importance of stabilizing PaCO2 during Long-term non-invasive ventilation in subjects with COPD.
|
|
86.
|
2014
|
|
Associations among chronic obstructive pulmonary disease and sleep-disordered breathing in an urban male working population in Japan.
|
|
87.
|
2014
|
|
Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
|
|
88.
|
2014
|
|
Differences in associations between visceral fat accumulation and obstructive sleep apnea by sex.
|
|
89.
|
2014
|
|
Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
|
|
90.
|
2014
|
|
Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels.
|
|
91.
|
2014
|
|
Reanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classification.
|
|
92.
|
2014
|
|
The additive impact of periodic limb movements during sleep on inflammation in obstructive sleep apnea patients.
|
|
93.
|
2014
|
|
The importance of controlling PaCO2 throughout long-term noninvasive ventilation.
|
|
94.
|
2014
|
|
Towards the next stage of novel biomarker discussion in COPD: Tekizai-Tekisho.
|
|
95.
|
2013
|
|
A prospective study analyzing one-year multidimensional outcomes in living lung transplant donors.
|
|
96.
|
2013
|
|
A urine biomarker for severe OSA patients: lipocaline-type prostaglandin D synthase.
|
|
97.
|
2013
|
|
Analysis of systemic and airway inflammation in obstructive sleep apnea.
|
|
98.
|
2013
|
|
Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxia.
|
|
99.
|
2013
|
|
Clinical relevance of plasma prostaglandin F2a metabolite concentrations in patients with idiopathic pulmonary fibrosis.
|
|
100.
|
2013
|
|
Flexible positive airway pressure improves treatment adherence compared with auto-adjusting PAP.
|
|
101.
|
2013
|
|
HRCT findings as determinants of health-related quality of life in Mycobacterium avium complex disease.
|
|
102.
|
2013
|
|
Impaired endothelium-dependent vasodilator response in patients with pulmonary fibrosis.
|
|
103.
|
2013
|
|
Measurement of dyspnea in patients with obstructive sleep apnea.
|
|
104.
|
2013
|
|
Predictive factors for reintubation following noninvasive ventilation in patients with respiratory complications after living donor liver transplantation.
|
|
105.
|
2013
|
|
Roles of eicosanoids in pulmonary fibrosis.
|
|
106.
|
2013
|
|
The prognostic value of HRCT in myositis-associated interstitial lung disease.
|
|
107.
|
2012
|
|
Analysis of anatomical and functional determinants of obstructive sleep apnea.
|
|
108.
|
2012
|
|
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.
|
|
109.
|
2012
|
|
Differences in relationships among sleep apnoea, glucose level, sleep duration and sleepiness between persons with and without type 2 diabetes.
|
|
110.
|
2012
|
|
Expression of prostaglandin F receptor in scleral and subconjuctival tissue.
|
|
111.
|
2012
|
|
Impact of nasal continuous positive airway pressure for congenital adrenal hyperplasia with obstructive sleep apnea and bruxism.
|
|
112.
|
2012
|
|
Nocturia in male patients with obstructive sleep apnea: efficacy of medication for benign prostate hypertrophy.
|
|
113.
|
2012
|
|
Relationships of decreased lung function with metabolic syndrome and obstructive sleep apnea in Japanese males.
|
|
114.
|
2012
|
|
Streptococcus pneumoniae urinary antigen test and acute exacerbation of chronic obstructive pulmonary disease.
|
|
115.
|
2012
|
|
Transient increase in epileptiform discharges after the introduction of nasal continuous positive airway pressure in a patient with obstructive sleep apnea and epilepsy.
|
|
116.
|
2011
|
|
Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?
|
|
117.
|
2011
|
|
Clinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experience.
|
|
118.
|
2011
|
|
Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea.
|
|
119.
|
2011
|
|
Effects of the presence of hypertension on the relationship between obstructive sleep apnoea and sleepiness.
|
|
120.
|
2011
|
|
Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease.
|
|
121.
|
2011
|
|
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody.
|
|
122.
|
2011
|
|
Immediate noninvasive ventilation may improve mortality in patients with hepatopulmonary syndrome after liver transplantation.
|
|
123.
|
2011
|
|
PaCO2 six months after the initiation of long-term noninvasive ventilation in patients with COPD.
|
|
124.
|
2011
|
|
Predictive properties of different multidimensional staging systems in patients with COPD.
|
|
125.
|
2011
|
|
TRPA1 underlies a sensing mechanism for O2.
|
|
126.
|
2011
|
|
Validation of the Japanese version of the sarcoidosis health questionnaire: A cross-sectional study.
|
|
127.
|
2010
|
|
Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan.
|
|
128.
|
2010
|
|
Avoidance of reintubation by using sedation during noninvasive positive pressure ventilation in a 3-month-old infant with postoperative respiratory failure.
|
|
129.
|
2010
|
|
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial.
|
|
130.
|
2010
|
|
Importance of the PaCO2 from 3 to 6 months after initiation of long-term non-invasive ventilation.
|
|
131.
|
2010
|
|
Long-term nasal continuous positive airway pressure treatment lowers blood pressure in patients with obstructive sleep apnea regardless of age.
|
|
132.
|
2010
|
|
Multidimensional analyses of long-term clinical courses of asthma and chronic obstructive pulmonary disease.
|
|
133.
|
2010
|
|
Noninvasive ventilation improves the outcome of pulmonary complications after liver resection.
|
|
134.
|
2010
|
|
Relationship between peripheral airway function and patient-reported outcomes in COPD: a cross-sectional study.
|
|
135.
|
2010
|
|
Relationship between small airway function and health status, dyspnea and disease control in asthma.
|
|
136.
|
2009
|
|
A case of diffuse infiltrative lung disease with chronic vomiting after gastrectomy.
|
|
137.
|
2009
|
|
Computed tomography analysis of airway dimensions and lung density in patients with sarcoidosis
|
|
138.
|
2009
|
|
Effect of exacerbations on health status in subjects with chronic obstructive pulmonary disease.
|
|
139.
|
2009
|
|
Effects of obstructive sleep apnea with intermittent hypoxia on platelet aggregability.
|
|
140.
|
2009
|
|
Importance of ventilator mode in long-term noninvasive positive pressure ventilation.
|
|
141.
|
2009
|
|
Long-term complications and prognosis of chronic beryllium disease.
|
|
142.
|
2009
|
|
Prostaglandin F2areceptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-B
|
|
143.
|
2008
|
|
Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment.
|
|
144.
|
2008
|
|
Alcohol consumption in patients with chronic obstructive pulmonary disease in Japan.
|
|
145.
|
2008
|
|
Comparison of health-related quality of life measurements using a single value in patients with asthma and chronic obstructive pulmonary disease.
|
|
146.
|
2008
|
|
Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure.
|
|
147.
|
2007
|
|
Analysis of longitudinal changes in the psychological status of patients with asthma.
|
|
148.
|
2007
|
|
Longitudinal deteriorations in patient reported outcomes in patients with COPD.
|
|
149.
|
2006
|
|
Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD.
|
|
150.
|
2005
|
|
"MORTALITY" in OUTCOMES AND MARKERS IN COPD.
|
|
151.
|
2005
|
|
Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years.
|
|
152.
|
2005
|
|
Longitudinal changes in patient vs. physician-based outcome measures did not significantly correlate in asthma.
|
|
153.
|
2004
|
|
A comparison of two simple measures to evaluate the health status of asthmatics: the Asthma Bother Profile and the Airways Questionnaire 20
|
|
154.
|
2004
|
|
Development and psychometric analysis of the Japanese version of the Nottingham Health Profile: cross-cultural adaptation.
|
|
155.
|
2004
|
|
Exercise responses during endurance testing at different intensities in patients with COPD.
|
|
156.
|
2004
|
|
Health-related quality of life in stable asthma: What are remaining quality of life problems in patients with well-controlled asthma?
|
|
157.
|
2004
|
|
Longitudinal changes in health status using the Chronic Respiratory Disease Questionnaire and pulmonary function in patients with stable COPD.
|
|
158.
|
2004
|
|
Possible maximal change in the SF-36 of outpatients with chronic obstructive pulmonary disease and asthma.
|
|
159.
|
2003
|
|
A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
|
|
160.
|
2003
|
|
A comparison of the responsiveness of different generic health status measures in patients with asthma.
|
|
161.
|
2003
|
|
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status.
|
|
162.
|
2003
|
|
Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD.
|
|
163.
|
2002
|
|
Comparison of the responsiveness of different disease-specific health status measures in patients with asthma.
|
|
164.
|
2002
|
|
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with chronic obstructive pulmonary disease.
|
|
165.
|
2002
|
|
Health status measured with the CRQ does not predict mortality in COPD.
|
|
166.
|
2002
|
|
Longitudinal changes in airflow limitation and airway hyperresponsiveness in patients with stable asthma.
|
|
167.
|
2002
|
|
Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease.
|
|
168.
|
2001
|
|
A comparison of the individual best versus the predicted peak expiratory flow in patients with chronic asthma.
|
|
169.
|
2001
|
|
Changes in indices of airway hyperresponsiveness during one year of treatment with inhaled corticosteroids in patients with asthma
|
|
170.
|
2000
|
|
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.
|
|
171.
|
2000
|
|
The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
|
|
172.
|
1999
|
|
A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.
|
|
Display 5 items
|
|
Display all(172)
|
